Macular Degeneration Trial, Recruiting NCT06755372 Sponsor: Ain Shams University Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT06755372
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 – Generally Healthy People with Gum Disease:

  • You are between 30 and 60 years old
  • You are male or female
  • You have been diagnosed with moderate to severe gum disease (called periodontitis stage II or III)
  • You do not have any other health conditions
  • You are not taking any long-term regular medications

Group 2 – Kidney Failure Patients with Gum Disease:

  • You are between 30 and 60 years old
  • You are male or female
  • You have been diagnosed with end-stage kidney failure and are regularly receiving dialysis treatment
  • You have been diagnosed with moderate to severe gum disease (called periodontitis stage II or III)
  • You are Egyptian, unrelated to other participants, from a similar financial background, and living in the same general area (confirm with trial site)
  • You have been diagnosed with type 2 diabetes

Who may not be able to join:

Group 1:

  • You are a current smoker
  • You have any ongoing health condition or take long-term regular medications

Group 2:

  • You have had a kidney transplant
  • You have any health condition other than diabetes
  • You have a history of cancer
  • You are a current smoker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fatma E. A. Hassanein, PHD, king Salman Intwenational University University

Phone: 01000093885

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 July 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Clinical Attachment Level (CAL):

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov